Rahmer Peter
Known title: See remarksCIK: 0001959229
Associated companies
Transaction History
| RLAY | ▼ Sell | Open Market | 4,508 | $90K | 8/26/2026 | View on chart |
| RLAY | ▼ Sell | Open Market | 748 | $14K | 7/28/2026 | View on chart |
| RLAY | ▼ Sell | Open Market | 50,000 | $955K | 6/30/2026 | View on chart |
| RLAY | ▲ Buy | Grant | 3,056 | $21K | 6/30/2026 | View on chart |
| RLAY | ▼ Sell | Open Market | 753 | $11K | 4/28/2026 | View on chart |
| RLAY | ▼ Sell | Open Market | 1,354 | $11K | 1/28/2026 | View on chart |
| RLAY | ▼ Sell | Open Market | 11,684 | $89K | 1/27/2026 | View on chart |
| RLAY | ▲ Buy | Grant | 994 | $3K | 12/31/2025 | View on chart |
| RLAY | ▼ Sell | Open Market | 21,394 | $160K | 10/29/2025 | View on chart |
| RLAY | ▼ Sell | Open Market | 19,135 | $139K | 10/28/2025 | View on chart |
| RLAY | ▼ Sell | Open Market | 15,724 | $58K | 7/29/2025 | View on chart |
| RLAY | ▼ Sell | Open Market | 1,359 | $5K | 7/28/2025 | View on chart |
| RLAY | ▲ Buy | Grant | 5,000 | $15K | 6/30/2025 | View on chart |
| RLAY | ▼ Sell | Open Market | 10,739 | $32K | 4/30/2025 | View on chart |
| RLAY | ▼ Sell | Open Market | 1,364 | $4K | 4/28/2025 | View on chart |
| RLAY | ▼ Sell | Open Market | 247 | $701 | 3/27/2025 | View on chart |
| RLAY | ▼ Sell | Open Market | 17,250 | $76K | 1/30/2025 | View on chart |
| RLAY | ▼ Sell | Open Market | 26,541 | $121K | 1/29/2025 | View on chart |
| RLAY | ▼ Sell | Open Market | 1,673 | $8K | 1/28/2025 | View on chart |
| RLAY | ▲ Buy | Grant | 139,141 | $0 | 1/28/2025 | View on chart |
| RLAY | ▼ Sell | Open Market | 16,576 | $74K | 1/6/2025 | View on chart |
| RLAY | ▼ Sell | Open Market | 32,177 | $138K | 1/3/2025 | View on chart |
| RLAY | ▼ Sell | Open Market | 32,156 | $133K | 1/2/2025 | View on chart |
| RLAY | ▼ Sell | Open Market | 400 | $2K | 12/27/2024 | View on chart |
| RLAY | ▼ Sell | Open Market | 1,621 | $10K | 10/28/2024 | View on chart |
| RLAY | ▼ Sell | Open Market | 245 | $2K | 9/27/2024 | View on chart |
| RLAY | ▼ Sell | Open Market | 13,708 | $112K | 7/31/2024 | View on chart |
| RLAY | ▼ Sell | Open Market | 15,128 | $125K | 7/30/2024 | View on chart |
| RLAY | ▼ Sell | Open Market | 1,359 | $12K | 7/29/2024 | View on chart |
| RLAY | ▼ Sell | Open Market | 12,164 | $104K | 7/29/2024 | View on chart |
| RLAY | ▲ Buy | Grant | 2,108 | $12K | 6/30/2024 | View on chart |
| RLAY | ▼ Sell | Open Market | 245 | $2K | 6/27/2024 | View on chart |
| RLAY | ▼ Sell | Open Market | 20,450 | $144K | 6/5/2024 | View on chart |
| RLAY | ▼ Sell | Open Market | 40,595 | $270K | 6/4/2024 | View on chart |
| RLAY | ▼ Sell | Open Market | 19,864 | $129K | 6/3/2024 | View on chart |
| RLAY | ▼ Sell | Open Market | 1,345 | $9K | 4/29/2024 | View on chart |
| RLAY | ▼ Sell | Open Market | 298 | $2K | 3/27/2024 | View on chart |
| RLAY | ▼ Sell | Open Market | 1,651 | $16K | 1/29/2024 | View on chart |
| RLAY | ▲ Buy | Grant | 200,000 | $0 | 1/16/2024 | View on chart |
| RLAY | ▼ Sell | Open Market | 244 | $3K | 12/27/2023 | View on chart |
| RLAY | ▼ Sell | Open Market | 1,354 | $8K | 10/30/2023 | View on chart |
| RLAY | ▼ Sell | Open Market | 244 | $2K | 9/27/2023 | View on chart |
| RLAY | ▼ Sell | Open Market | 1,352 | $16K | 7/28/2023 | View on chart |
| RLAY | ▲ Buy | Grant | 1,662 | $18K | 6/30/2023 | View on chart |
| RLAY | ▼ Sell | Open Market | 244 | $3K | 6/27/2023 | View on chart |
| RLAY | ▲ Buy | Grant | 161,818 | $0 | 5/30/2023 | View on chart |
| RLAY | ▼ Sell | Open Market | 739 | $8K | 4/28/2023 | View on chart |
| RLAY | ▼ Sell | Open Market | 297 | $5K | 3/27/2023 | View on chart |
| RLAY | ▼ Sell | Open Market | 740 | $16K | 1/30/2023 | View on chart |
| RLAY | ▲ Buy | Grant | 97,630 | $0 | 1/17/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
RLAY Valuation Debate: Is the Pullback a Value Trap?
Recent analysis questions whether Relay Therapeutics is undervalued after its recent price drop or if the market has already priced in potential gains. One report suggests the stock is fully priced relative to its book value, while another asks if the current level offers a bargain. The stock is currently trading near a key support level, with analysts maintaining a higher average target price.
RLAY Valuation Debate: Is the Pullback a Value Trap?. Recent analysis questions whether Relay Therapeutics is undervalued after its recent price drop or if the market has already priced in potential gains. One report suggests the stock is fully priced relative to its book value, while another asks if the current level offers a bargain. The stock is currently trading near a key support level, with analysts maintaining a higher average target price.